Leadership

Dr. Suzan Davis

Suzan Davis portrait

CEO, President & Founder

Dr. Davis is a pharmacist by training and holds a Master’s in Regulatory Affairs (MRA) and a Master’s in Business Administration (MBA) from Northeastern University.

With more than 24 years of experience in strategic planning, regulatory affairs strategy, regulatory submissions, clinical trial operations and management.

Dr Suzan S. Davis, President and CEO

As founder, President and CEO of Global Regulatory Partners Inc. (GRP), Dr. Suzan Davis provides the overall leadership, business strategy and day to day management at GRP. Her unique and extensive profile includes her experiences with various pharma, biotech and medical device companies. Her impressive international experience encompasses work in the United States, Europe, Latin America and Asia.

She has been directly involved in building Global Regulatory Partner’s team of highly motivated and talented professionals with the appropriate skills, expertise and experience in regulatory affairs, clinical, safety and quality.

Dr. Davis has more than 24 years of experience in strategic planning, regulatory affairs strategy, regulatory submissions, clinical trial operations and management, adverse event reporting and management, quality audits, licensing, CMC, technical transfer and business development within life sciences industry.

Dr. Davis assumed many leadership, senior management and consulting roles in large and small biotech, pharma and medical device companies such as GSK, Pfizer, Genzyme , EMD Sereno, Millennium/Takeda , Forum Pharmaceuticals, Olympus, Smith and Nephew in United States and international markets as well.

During her career, she managed many new products’ development projects and clinical trials in United States and outside United States. In addition to that, she prepared and submitted many IND, NDA, ANDA, BLA, IDE, 510(K), PMA, CE marking to FDA , EMA and other health authorities in Asia and Latin America.

As certified quality auditor by ASQ she conducted many GMP, ISO 13485 and due diligence audits for multiple pharmaceutical and medical device companies in United States, Europe, Asia and Latin America. She also helped many life science companies in the implementation and maintenance of their quality systems in compliance with FDA and ISO 13485 requirements.

Suzan Davis received a PharmD from pharmacy college (Université Paris 1 Panthéon-Sorbonne) in Paris, a Master in Regulatory Affairs (MRA) and a Master in Business Administration (MBA) from Northeastern University in Boston. She is also a certified quality auditor by ASQ , she is certified in US regulatory affairs ( RAC US) and certified in European regulatory affairs (RAC EU) by Regulatory Affairs Professional Society (RAPS).

Read More

Gregorio Corrado

Gregorio Corrado portrait

Chief Financial Officer

Greg has more than 25 years of Financial Management and Operations Analysis experience. Greg brings a strong background to oversee GRP’s Finance and Accounting.

Greg holds an MBA from Babson College.

Gregorio Corrado, Chief Financial Officer

Gregorio Corrado  has with more than 25 years of Financial Management and Operations Analysis experience. Greg brings a strong background to oversee GRP’s Finance and Accounting functions. Greg has consulted to such diverse firms as Gillette and State Street Corporation, as well as to clients in the Communications, Real Estate, and Architecture fields.

Greg has consulted to such diverse firms as Gillette and State Street Corporation, as well as to clients in the Communications, Real Estate, and Architecture fields. His principal focus is upon financial and accounting controls, procedures and process efficiency, in addition to the application of analytical methods to business assessment and planning. As a Director with Fidelity Investments, he led a team of business and operations analysts, and he served as a Senior Analyst with MIT Lincoln Laboratory. Greg is also the principal at Dover Analytics, where he provides analytical services such as due diligence examinations of private equity investments for high net worth investors and financial consulting to small- and medium-size businesses.

Greg holds a bachelor’s degree in Medieval and Renaissance Studies from Boston University, and an MBA from Babson College.

Read More

Jan Peterson

VP of Regulatory Affairs & Quality

With over 40 years of experience in Regulatory Affairs, Clinical Research Design, Trial Management, Quality Assurance Monitoring and Quality Auditing within the pharmaceutical and medical industry.

Mr. Peterson holds a master’s in pharmacology and Experimental Therapeutics from the University of California industry.

Jan Peterson, VP of Regulatory Affairs & Quality

Mr. Jan Peterson has over 40 years of experience in Regulatory Affairs, Clinical Research Design, Trial Management, Quality Assurance Monitoring and Quality Auditing within the pharmaceutical and medical device industry. Before joining Global Regulatory Partners, Inc., Jan was a Director of Regulatory Affairs and a Project Manager at the Emmes Corporation (a CRO), where he supported the development of multiple drugs and medical devices for over 100 clinical trials in 15 countries. Some of those clinical trials were conducted under INDs for the Best Pharmaceuticals for Children Act (BPCA) sponsored by NICHD, or under INDs sponsored by the NEI at NIH (National Institutes of Health) as well as commercial sponsors.

Mr. Peterson has and maintains strong professional relationships with FDA regulators at CDER, CBER, and CDRH, as he had submitted many INDs and 510(k)s to FDA, and had organized and attended many pre-consultation meetings with FDA and with FDA Advisory Panels on behalf of sponsors.

As a Good Clinical Practice (GCP) certified auditor, he conducted many GCP audits and provided GCP trainings to sponsors, clinical investigators and CRAs. Additionally, he performed clinical study monitoring for various sponsors at over 100 clinical trial sites and associated laboratories in the United States, Canada, Latin America, Europe and Asia.

Mr. Peterson holds a master’s in pharmacology and Experimental Therapeutics from the University of California at San Francisco and a bachelor’s in biology, Chemistry, and Biomedical Science from St. Cloud State University. He is also a Certified Biomedical Auditor (CBA) by the American Society for Quality, a Certified Regulatory Affairs (RAC) professional by the Regulatory Affairs Professionals Society, a Certified Clinical Research Associate (CCRA) by the Academy of Clinical Research Professionals and an ACRP Certified Professional (ACRP-CP). Jan has also been intensively trained in GCP, human subject’s protection (HSP), and in information security and privacy awareness through NIH and CITI programs as required for US government contractors and sub-contractors. Mr. Peterson has a significant track record as first author or co-author of over 20 peer- reviewed scientific publications and over 40 presentations at professional society meetings.

Read More

Yogi Raj

VP, International Business Development

Yogi has over 15 years of experience working in regulatory affairs, biopharma competitive intelligence, licensing and business development.

Yogi has a bachelor’s in technology in Biotechnology from Jaypee Institute of Information Technology and is a certified PRINCE2 Project Management Practitioner from APMG, UK.

Yogi Raj, VP, International Business Development

Yogi has worked in regulatory affairs, biopharma competitive intelligence, licensing and business development for over 15 years. Before joining Global Regulatory Partners, he has held many management positions in regulatory affairs, pharma commercial portfolio management, business development in leading organizations providing cutting edge decision support solutions, regulatory affairs business consulting services and technologies. Yogi has unique combination of expertise in pharmaceutical, nutraceuticals, cosmetics and devices product lifecycle management, automation of regulatory processes, regulatory operations excellence, global commercial strategy for life sciences companies and has helped many companies achieve their global commercial goals in over 50 countries across North America, Europe, Asia, Middle East, Latin America and Africa.

Yogi has enabled several multi-million, global licensing deals and has led several innovation initiatives for regulatory affairs working with large pharma and biotech companies leading to operational excellence creating additional value for companies. He has built teams, organizations in uniquely placed, new companies using non-linear growth methodologies and has helped organizations realize their full potential for value creation. Yogi has a bachelor’s in technology in Biotechnology from Jaypee Institute of Information Technology and is a certified PRINCE2 Project Management Practitioner from APMG, UK.  

Read More

Useful Links

Resources

What our Clients say about Us

Thank you GRP team for registering our DMF in china. Your helped us achieve a big milestone for our company. The support and the commitment of your regulatory team have exceeded our expectations and made it easier for us to communicate with NMPA the Chinese authority. All the best !
Director of Regulatory Affairs Officer- CMC- A Large European Pharmaceutical Company based in Switzerland
We have been working with Global Regulatory Partners for 5 years and we consider them as our real partner and not as a consulting company, they had submitted 3 INDs for us with FDA successfully . The GRP team performs all IND amendments and annual reporting to FDA, we don’t have to worry about not being in compliance with FDA requirements at all.
CEO of Medium Size American Pharmaceutical Company operating in Nanotechnology based in USA
We hired Global Regulatory Partners to perform a clinical study for our company in China. We have been looking for 1 year to find the right CRO that understand the Chinese regulations, European , consider them as our real partner and not as a consulting company, they had submitted 3 INDs for us with FDA successfully . The GRP team performs all IND amendments and annual reporting to FDA, we don’t have to worry about not being in compliance with FDA requirements at all.
CMO of Large European Pharmaceutical Company based in France and Operating in Radiopharmaceuticals
I am very impressed on how quickly Global Regulatory Affairs team was able to prepare and organize a face to face consultation meeting for our company with Anvisa in Brazil, The meeting was successful and helped us to validate and conform the regulatory strategy of our device registration in Brazil.
VP of Global Regulatory Affairs, American Based Medical device Company

Copyright ©2019 Global Regulatory Partners

Scroll to Top

Contact